A Study of Intravenous Isavuconazonium Sulfate in Pediatric Patients

Official Title: A Phase 1, Open-label, Multicenter, Non-comparative Pharmacokinetics and Safety Study of Intravenous Isavuconazonium Sulfate in Pediatric Patients

The purpose of the study is to evaluate the pharmacokinetics (PK), safety and tolerability of multiple doses of intravenous (IV) isavuconazonium sulfate administered daily in pediatric patients. The PK data will be utilized to establish a pediatric population PK model of isavuconazole, the active moiety of isavuconazonium sulfate.

NCT03241550
Muller, William J., MD, PhD
Interventional
Yes

Contact Information:

Laura Fearn

Nurse Coordinator

312.227.6285